Palatin (PLTN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Palatin (PLTN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: rareearth42	8/24/2006 11:13:23 PM
	Read Replies (1) of 61

Well, if there's anyone reading this board, we're coming down to the wire for the results from the two phase 2b trials of bremelanotide. We were promised that the topline data from the roughly 800 patients studies would be announced "end of August, or early September". King Pharma, which inked a deal worth up to 1/4 Billion dollars with PTN, re-designed and repeated the phase 2b trials to be sure they have the right dose before conducting expensive registration trials. I think the investment community at large will judge the value of bremelanotide, and thereby PTN, by the results of these large, well-designed studies. Accordingly, I expect PTN will pop or drop in the next few weeks. As I posted on the Yahoo board before I left in disgust over their simply awful redesigned message board, this is one of the few cases where the direction of the company's stock price will be indicated by the male members of the treated patients......I'm betting both will head skyward! RE42

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next